Anti-S26A8/ SLC26A8/ SPGF3 monoclonal antibody

Anti-S26A8/ SLC26A8/ SPGF3 antibody for FACS & in-vivo assay

Target products collectionGo to SLC26A8/SLC26A8 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1579-Ab-1/ GM-Tg-hg-MP1579-Ab-2Anti-Human SLC26A8 monoclonal antibodyHuman
GM-Tg-rg-MP1579-Ab-1/ GM-Tg-rg-MP1579-Ab-2Anti-Rat SLC26A8 monoclonal antibodyRat
GM-Tg-mg-MP1579-Ab-1/ GM-Tg-mg-MP1579-Ab-2Anti-Mouse SLC26A8 monoclonal antibodyMouse
GM-Tg-cynog-MP1579-Ab-1/ GM-Tg-cynog-MP1579-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC26A8 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1579-Ab-1/ GM-Tg-felg-MP1579-Ab-2Anti-Feline SLC26A8 monoclonal antibodyFeline
GM-Tg-cang-MP1579-Ab-1/ GM-Tg-cang-MP1579-Ab-2Anti-Canine SLC26A8 monoclonal antibodyCanine
GM-Tg-bovg-MP1579-Ab-1/ GM-Tg-bovg-MP1579-Ab-2Anti-Bovine SLC26A8 monoclonal antibodyBovine
GM-Tg-equg-MP1579-Ab-1/ GM-Tg-equg-MP1579-Ab-2Anti-Equine SLC26A8 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1579-Ab-1/ GM-Tg-hg-MP1579-Ab-2; GM-Tg-rg-MP1579-Ab-1/ GM-Tg-rg-MP1579-Ab-2;
GM-Tg-mg-MP1579-Ab-1/ GM-Tg-mg-MP1579-Ab-2; GM-Tg-cynog-MP1579-Ab-1/ GM-Tg-cynog-MP1579-Ab-2;
GM-Tg-felg-MP1579-Ab-1/ GM-Tg-felg-MP1579-Ab-2; GM-Tg-cang-MP1579-Ab-1/ GM-Tg-cang-MP1579-Ab-2;
GM-Tg-bovg-MP1579-Ab-1/ GM-Tg-bovg-MP1579-Ab-2; GM-Tg-equg-MP1579-Ab-1/ GM-Tg-equg-MP1579-Ab-2
Products NameAnti-SLC26A8 monoclonal antibody
Formatmab
Target NameSLC26A8
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SLC26A8 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species S26A8/ SLC26A8/ SPGF3 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1579
    Target NameSLC26A8
    Gene ID116369,224661,309646,719049,474888,101091284,530509,100063498
    Gene Symbol and SynonymsAZON,SLC26A8,SPGF3,TAT1
    Uniprot AccessionQ96RN1,A6QNW6
    Uniprot Entry NameS26A8_HUMAN,S26A8_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000112053
    Target ClassificationN/A

    The target: SLC26A8, gene name: SLC26A8, also named as SPGF3, TAT1. This gene encodes a member of the SLC26 gene family of anion transporters. Family members are well conserved in gene structure and protein length yet have markedly different tissue expression patterns. The expression of this gene appears to be restricted to spermatocytes. Alternatively spliced transcript variants that encode different isoforms have been described. [provided by RefSeq, Jul 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.